View Older Stories View More Recent Stories
-
Jersey Mike's launches IPO roadshow, targets NYSE listing as JMKE
-
Jersey Mike's Announces Launch of Initial Public Offering
-
JAB Holdings B.V. Commences Tender Offers for Any and All of Its 2.200% Senior Notes Due 2030, 3.750% Senior Notes Due 2051 and 4.500% Sustainability-Linked Senior Notes Due 2052
-
RBC Capital Upgrades Atalaya Mining Plc. (ATYM:LN) to Outperform
-
RBC Capital Starts DPC Holdings PLC (DPC) at Outperform
-
Factbox-US restaurant chains hit by foodborne illness outbreaks
-
RBC Capital Assumes Life360 Inc (360:AU) at Outperform
-
RBC Capital Assumes Zip Co Ltd (ZIP:AU) (ZIZTF) at Outperform
-
RBC Capital Downgrades Telix Pharmaceuticals Ltd (TLX:AU) (TLX) to Sector Perform
-
BNY prices $500M preferred stock depositary share offering
-
BNY Announces Pricing of Public Offering of $500,000,000 of Depositary Shares Representing Interests in Preferred Stock
-
Apotex gets BBB (low) rating, revises credit deal with $1.2B facility
-
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
-
Heico closes $1.2 billion senior notes offering to repay debt
-
HEICO Corporation Closes $1.2 Billion Senior Notes Offering
-
PNC Financial (PNC) PT Raised to $273 at RBC Capital
-
The Bank of New York Mellon Corporation (BNY) PT Raised to $168 at RBC Capital
-
ConAgra (CAG) PT Lowered to $14 at RBC Capital
-
Elevance (ELV) PT Lowered at RBC Capital; 'Solid results but short of elevated expectations'
-
ASML Inc. (ASML) PT Raised to $2,100 at RBC Capital
-
Airbus (AIR:FP) (EADSY) PT Raised to EUR215 at RBC Capital
-
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal
-
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
-
RBC Capital Downgrades ResMed (RMD) to Sector Perform
-
RBC Capital Upgrades Compagnie Financiere Richemont SA (CFR:SW) (CFRUY) to Outperform
-
Csquare prices IPO at $21 per share on NYSE
-
Csquare, Inc. Announces Pricing of Initial Public Offering
-
Standard Nuclear prices IPO at $15 per share on NYSE
-
Standard Nuclear Announces Pricing of its Initial Public Offering
-
Obsidian Energy Announces $75 million Add-On to our Existing Senior Unsecured Notes
-
Brompton Split Banc Corp. Announces Successful Preferred Share Offering
-
William Blair Hires Head of Biopharma Investment Banking, based in New York
-
Ligand Pharma (LGND) PT Raised to $340 at RBC Capital
-
JPMorgan (JPM) PT Raised at RBC Capital as 'Capital Markets Drives Better Than Expected Results'
-
HCA Healthcare Inc (HCA) PT Lowered to $435 at RBC Capital
-
Bank of America (BAC) PT Raised to $65 at RBC Capital
-
GE Aerospace (GE) PT Raised to $400 at RBC Capital
-
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
-
Trace3 Says AI's Production Gap Is Not a Technology Problem
-
Conagra reviews non-core assets after slashing dividend, issuing weak outlook
-
Standard Nuclear slashes IPO plans to 10 million shares
-
RBC Capital Downgrades Pentair (PNR) to Sector Perform
-
Attovia Therapeutics files for IPO on Nasdaq
-
Apollo funds complete acquisitions of Emerald and Questex
-
Apollo Funds Complete Acquisitions of Emerald and Questex, Creating a Scaled, B2B Experiential Events and Media Platform Positioned to Drive Sustained, Long-Term Growth
-
Apollo Funds Complete Acquisitions of Emerald and Questex, Creating a Scaled, B2B Experiential Events and Media Platform Positioned to Drive Sustained, Long-Term Growth
-
Form MA-I/A RBC Capital Markets,
-
Life & Banc Split Corp. Completes Preferred Share Offering
-
MDA Space raises $819M in share offering to fund CLS acquisition
-
MDA SPACE ANNOUNCES CLOSING OF ITS UPSIZED BOUGHT DEAL OFFERING OF COMMON SHARES
